fda 503a bulks list bpc-157 category 2 The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC-157 just got voted in
BPC 157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank BPC 157 FDA Approval Status 2026: Clinical Trials FDA's July 2026 Peptide Compounding Meeting: What PCAC Could Change for BPC 157, TB 500, Semax, and More PeptideKnow FDA Pharmacy Compounding Committee Votes on Peptide Policy John Hoekman posted on the topic LinkedIn Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma bpc 157 regulation fda fda bpc 157 category 2 bulk drug substances compounding list When will the FDA reclassify BPC 157 to Category 1
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



